WASHINGTON — Alec Bohm’s 2024 season did not end so much as it faded away, a digression that culminated when he was benched during the Philadelphia Phillies’ defeat at the hands of the New ...

A federal judge is giving the state and consumers in the state’s CDPAP two more days to negotiate the terms of a preliminary ...

NYU Langone Health tapped Alec Kimmelman to succeed Robert Grossman as its next CEO and dean of the NYU Grossman School of ...

NYU Langone Health on Monday named Dr. Alec Kimmelman as its next CEO and dean of New York University's Grossman School of Medicine. Kimmelman, who has been leading NYU Langone's Laura and Isaac ...

The appointment comes almost a year after Grossman and Kenneth Langone, chair of NYU’s board of trustees, announced their ...

The announcement by NYU Langone’s Board of Trustees was praised by Kenneth Langone, board chair and co-chair of the search ...

Circle Pharma, a clinical-stage biopharmaceutical company focused on developing cell-permeable macrocycle therapeutics, today announced that Chief Executive Officer David Earp, JD, Ph.D., will present ...

VolitionRx Limited ("Volition"), a multi-national epigenetics company, today announces financial results and a business update for the fourth quarter and full fiscal year ended December 31, 2024. ...

Resolute Health Corp., Canada's largest privately held sleep health company with over 80 locations, is excited to announce its rebrand to Resolve Sleep Health. The new name reflects the company's ...

New York City based NYU Langone Health has selected Alec Kimmelman, MD, PhD, as the next CEO and dean of NYU Grossman School of Medicine, effective Sept. 1. Dr. Kimmelman, a researcher and radiation ...

Dr. Kimmelman's appointment was confirmed in a unanimous vote by NYU Langone's Board of Trustees. "We are excited to name Dr. Kimmelman to this position given his extraordinary talent, leadership ...